2013 annual financial data
Anika Therapeutics 2013 Operating margin
Direct answer
Operating margin was 43.43%.
Operating income was 32,606,717 USD and net income was 20,574,521 USD.
Operating cash flow was 25,165,000 USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 75,081,154 USD
- Operating income
- 32,606,717 USD
- Net income
- 20,574,521 USD
- Operating cash flow
- 25,165,000 USD